Oxford Eye Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Macular degeneration1 trial
• Retinitis pigmentosa1 trial

Phase

• Phase 21 trial
• Phase 2/31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Janssen Research & Development, LLC1 trial
• Laboratoires Thea1 trial

Running trials

• Active, not recruiting

  Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

  NCT06627179· Phase 2· Laboratoires Thea· Source

• Recruiting

  A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT06635148· Phase 2/3· Janssen Research & Development, LLC· Source